Helene Hallböök

Intensive chemotherapy for high-risk acute lymphoblastic leukemia in first remission: results from the NOPHO ALL2008 study

Nikkilä, Atte; Lohi, Olli; Abrahamsson, Jonas; Griskevicius, Laimonas et al.

Part of Leukemia, p. 215-218, 2025

• DOI for Intensive chemotherapy for high-risk acute lymphoblastic leukemia in first remission: results from the NOPHO ALL2008 study
• Download full text (pdf) of Intensive chemotherapy for high-risk acute lymphoblastic leukemia in first remission: results from the NOPHO ALL2008 study

High Prevalence of Psychological Symptoms, Sexual Dysfunction, and Prolonged Medical Leave Two Years After Acute Leukemia Diagnosis-Patient Reported Outcome in Sweden

Lennmyr, Emma; Lübking, Anna; Abrahamsson, Marie; Juliusson, Gunnar et al.

Part of eJHaem, 2025

• DOI for High Prevalence of Psychological Symptoms, Sexual Dysfunction, and Prolonged Medical Leave Two Years After Acute Leukemia Diagnosis-Patient Reported Outcome in Sweden
• Download full text (pdf) of High Prevalence of Psychological Symptoms, Sexual Dysfunction, and Prolonged Medical Leave Two Years After Acute Leukemia Diagnosis-Patient Reported Outcome in Sweden

Impact of age and sex on survival outcomes inpatients aged 1-45 years with acute lymphoblastic leukemia treated according to the stratification used in the NOPHO ALL2008 trial

Taalas, Tuomas Lahteenmaki; Oskarsson, Trausti; Heyman, Mats; Lund, Bendik et al.

Part of Haematologica, p. 1723-1735, 2025

• DOI for Impact of age and sex on survival outcomes inpatients aged 1-45 years with acute lymphoblastic leukemia treated according to the stratification used in the NOPHO ALL2008 trial
• Download full text (pdf) of Impact of age and sex on survival outcomes inpatients aged 1-45 years with acute lymphoblastic leukemia treated according to the stratification used in the NOPHO ALL2008 trial

Stratification and Treatment of Adolescents and Young Adults with Acute Lymphoblastic Leukaemia

Hough, Rachael; Moorman, Anthony; Hallböök, Helene

Part of Acute Lymphoblastic Leukemia in Children and Adolescents, p. 125-133, Springer, 2024

• DOI for Stratification and Treatment of Adolescents and Young Adults with Acute Lymphoblastic Leukaemia

Increase in peg-asparaginase clearance as a predictor for inactivation in patients with acute lymphoblastic leukemia

Dam, Merete; Centanni, Maddalena; Friberg, Lena E.; Centanni, Daniel et al.

Part of Leukemia, p. 712-719, 2024

• DOI for Increase in peg-asparaginase clearance as a predictor for inactivation in patients with acute lymphoblastic leukemia
• Download full text (pdf) of Increase in peg-asparaginase clearance as a predictor for inactivation in patients with acute lymphoblastic leukemia

Intensive chemotherapy for high-risk acute lymphoblastic leukemia in first remission: results from the NOPHO ALL2008 study

Nikkilä, Atte; Lohi, Olli; Abrahamsson, Jonas; Griskevicius, Laimonas et al.

Part of Leukemia, p. 215-218, 2025

• DOI for Intensive chemotherapy for high-risk acute lymphoblastic leukemia in first remission: results from the NOPHO ALL2008 study
• Download full text (pdf) of Intensive chemotherapy for high-risk acute lymphoblastic leukemia in first remission: results from the NOPHO ALL2008 study

High Prevalence of Psychological Symptoms, Sexual Dysfunction, and Prolonged Medical Leave Two Years After Acute Leukemia Diagnosis-Patient Reported Outcome in Sweden

Lennmyr, Emma; Lübking, Anna; Abrahamsson, Marie; Juliusson, Gunnar et al.

Part of eJHaem, 2025

• DOI for High Prevalence of Psychological Symptoms, Sexual Dysfunction, and Prolonged Medical Leave Two Years After Acute Leukemia Diagnosis-Patient Reported Outcome in Sweden
• Download full text (pdf) of High Prevalence of Psychological Symptoms, Sexual Dysfunction, and Prolonged Medical Leave Two Years After Acute Leukemia Diagnosis-Patient Reported Outcome in Sweden

Impact of age and sex on survival outcomes inpatients aged 1-45 years with acute lymphoblastic leukemia treated according to the stratification used in the NOPHO ALL2008 trial

Taalas, Tuomas Lahteenmaki; Oskarsson, Trausti; Heyman, Mats; Lund, Bendik et al.

Part of Haematologica, p. 1723-1735, 2025

• DOI for Impact of age and sex on survival outcomes inpatients aged 1-45 years with acute lymphoblastic leukemia treated according to the stratification used in the NOPHO ALL2008 trial
• Download full text (pdf) of Impact of age and sex on survival outcomes inpatients aged 1-45 years with acute lymphoblastic leukemia treated according to the stratification used in the NOPHO ALL2008 trial

Increase in peg-asparaginase clearance as a predictor for inactivation in patients with acute lymphoblastic leukemia

Dam, Merete; Centanni, Maddalena; Friberg, Lena E.; Centanni, Daniel et al.

Part of Leukemia, p. 712-719, 2024

• DOI for Increase in peg-asparaginase clearance as a predictor for inactivation in patients with acute lymphoblastic leukemia
• Download full text (pdf) of Increase in peg-asparaginase clearance as a predictor for inactivation in patients with acute lymphoblastic leukemia

Impact of body mass index on outcome and treatment-related toxicity in young adults with acute lymphoblastic leukemia

Egnell, Christina; Hallböök, Helene; Heyman, Mats; Wartiovaara-Kautto, Ulla et al.

Part of Acta Oncologica, p. 1723-1731, 2023

• DOI for Impact of body mass index on outcome and treatment-related toxicity in young adults with acute lymphoblastic leukemia
• Download full text (pdf) of Impact of body mass index on outcome and treatment-related toxicity in young adults with acute lymphoblastic leukemia

Invasive fungal infection by Peziza ostracoderma in an immunocompromised patient

Kinch, Amelie; Furebring, Mia; Chryssanthou, Erja; Hallböök, Helene

Part of Medical Mycology Case Reports, p. 26-30, 2023

• DOI for Invasive fungal infection by Peziza ostracoderma in an immunocompromised patient
• Download full text (pdf) of Invasive fungal infection by Peziza ostracoderma in an immunocompromised patient

Cerebral sinovenous thrombosis and asparaginase re-exposure in patients aged 1-45 years with acute lymphoblastic leukaemia: A NOPHO ALL2008 study

Tiedemann Skipper, Mette; Utke Rank, Cecilie; Brunsvig Jarvis, Kirsten; Stensig Lynggaard, Line et al.

Part of eJHaem, p. 754-763, 2022

• DOI for Cerebral sinovenous thrombosis and asparaginase re-exposure in patients aged 1-45 years with acute lymphoblastic leukaemia: A NOPHO ALL2008 study
• Download full text (pdf) of Cerebral sinovenous thrombosis and asparaginase re-exposure in patients aged 1-45 years with acute lymphoblastic leukaemia: A NOPHO ALL2008 study

A Study Protocol for Validation and Implementation of Whole-Genome and -Transcriptome Sequencing as a Comprehensive Precision Diagnostic Test in Acute Leukemias

Berglund, Eva Caroline; Barbany, Gisela; Orsmark-Pietras, Christina; Fogelstrand, Linda et al.

Part of Frontiers in Medicine, 2022

• DOI for A Study Protocol for Validation and Implementation of Whole-Genome and -Transcriptome Sequencing as a Comprehensive Precision Diagnostic Test in Acute Leukemias
• Download full text (pdf) of A Study Protocol for Validation and Implementation of Whole-Genome and -Transcriptome Sequencing as a Comprehensive Precision Diagnostic Test in Acute Leukemias

Cytogenetic aberrations in adult acute lymphoblastic leukemia-A population-based study

Lennmyr, Emma Bergfelt; Engvall, Marie; Barbany, Gisela; Fogelstrand, Linda et al.

Part of eJHaem, p. 813-817, 2021

• DOI for Cytogenetic aberrations in adult acute lymphoblastic leukemia-A population-based study
• Download full text (pdf) of Cytogenetic aberrations in adult acute lymphoblastic leukemia-A population-based study

Value of flow cytometry for MRD-based relapse prediction in B-cell precursor ALL in a multicenter setting

Modvig, S.; Hallböök, Helene; Madsen, H. O.; Siitonen, S. et al.

Part of Leukemia, p. 1894-1906, 2021

• DOI for Value of flow cytometry for MRD-based relapse prediction in B-cell precursor ALL in a multicenter setting
• Download full text (pdf) of Value of flow cytometry for MRD-based relapse prediction in B-cell precursor ALL in a multicenter setting

Detection of leukemia gene fusions by targeted RNA-sequencing in routine diagnostics

Engvall, Marie; Cahill, Nicola; Jonsson, Britt-Inger; Hoglund, Martin et al.

Part of BMC Medical Genomics, 2020

• DOI for Detection of leukemia gene fusions by targeted RNA-sequencing in routine diagnostics
• Download full text (pdf) of Detection of leukemia gene fusions by targeted RNA-sequencing in routine diagnostics

Introducing Patient-Reported Outcome in the Acute Leukemia Quality Registries in Sweden

Lennmyr, Emma; Karlsson, Karin; Abrahamsson, Marie; Ebrahim, Feresthe et al.

Part of European Journal of Haematology, p. 571-580, 2020

• DOI for Introducing Patient-Reported Outcome in the Acute Leukemia Quality Registries in Sweden
• Download full text (pdf) of Introducing Patient-Reported Outcome in the Acute Leukemia Quality Registries in Sweden

T-cell acute lymphoblastic leukemia in patients 1-45 years treated with the pediatric NOPHO ALL2008 protocol

Quist-Paulsen, P.; Toft, N.; Heyman, M.; Abrahamsson, J. et al.

Part of Leukemia, p. 347-357, 2020

• DOI for T-cell acute lymphoblastic leukemia in patients 1-45 years treated with the pediatric NOPHO ALL2008 protocol

Survival in adult acute lymphoblastic leukaemia (ALL): A report from the Swedish ALL Registry

Lennmyr, Emma; Karlsson, Karin; Ahlberg, Lucia; Garelius, Hege et al.

Part of European Journal of Haematology, p. 88-98, 2019

• DOI for Survival in adult acute lymphoblastic leukaemia (ALL): A report from the Swedish ALL Registry
• Download full text (pdf) of Survival in adult acute lymphoblastic leukaemia (ALL): A report from the Swedish ALL Registry

Real-world data on first relapse of acute lymphoblastic leukemia in patients > 55 years

Lennmyr, Emma Bergfelt; Kozlowski, Piotr; Ahlberg, Lucia; Bernell, Per et al.

Part of Leukemia and Lymphoma, p. 2470-2473, 2018

• DOI for Real-world data on first relapse of acute lymphoblastic leukemia in patients > 55 years

A Phase I/IIa Trial Using CD19-Targeted Third-Generation CAR T Cells for Lymphoma and Leukemia

Enblad, Gunilla; Karlsson, Hannah; Gammelgård, Gustav; Wenthe, Jessica et al.

Part of Clinical Cancer Research, p. 6185-6194, 2018

• DOI for A Phase I/IIa Trial Using CD19-Targeted Third-Generation CAR T Cells for Lymphoma and Leukemia

Comparing osteonecrosis clinical phenotype, timing, and risk factors in children and young adults treated for acute lymphoblastic leukemia

Mogensen, Signe Sloth; Harila-Saari, Arja; Makitie, Outi; Myrberg, Ida Hed et al.

Part of Pediatric Blood & Cancer, 2018

• DOI for Comparing osteonecrosis clinical phenotype, timing, and risk factors in children and young adults treated for acute lymphoblastic leukemia

Thromboembolism in acute lymphoblastic leukemia: results of NOPHO ALL2008 protocol treatment in patients aged 1 to 45 years

Rank, Cecilie Utke; Toft, Nina; Tuckuviene, Ruta; Grell, Kathrine et al.

Part of Blood, p. 2475-2484, 2018

• DOI for Thromboembolism in acute lymphoblastic leukemia: results of NOPHO ALL2008 protocol treatment in patients aged 1 to 45 years

Results of NOPHO ALL2008 treatment for patients aged 1-45 years with acute lymphoblastic leukemia.

Toft, N; Birgens, H; Abrahamsson, J; Griškevičius, L et al.

Part of Leukemia, p. 606-615, 2018

• DOI for Results of NOPHO ALL2008 treatment for patients aged 1-45 years with acute lymphoblastic leukemia.

Long-term outcome of Epstein-Barr virus DNAemia and PTLD with the use of preemptive rituximab following allogeneic HSCT

Kinch, Amelie; Hallböök, Helene; Arvidson, Johan; Sällström, Kalle et al.

Part of Leukemia and Lymphoma, p. 1172-1179, 2018

• DOI for Long-term outcome of Epstein-Barr virus DNAemia and PTLD with the use of preemptive rituximab following allogeneic HSCT

Age but not Philadelphia positivity impairs outcome in older/elderly patients with acute lymphoblastic leukemia in Sweden

Kozlowski, Piotr; Lennmyr, Emma; Ahlberg, Lucia; Bernell, Per et al.

Part of European Journal of Haematology, p. 141-149, 2017

• DOI for Age but not Philadelphia positivity impairs outcome in older/elderly patients with acute lymphoblastic leukemia in Sweden
• Download full text (pdf) of Age but not Philadelphia positivity impairs outcome in older/elderly patients with acute lymphoblastic leukemia in Sweden

Epstein-Barr virus-related disease after allogeneic HSCT and use of pre-emptive rituximab: Clinical Features And Outcome

Kinch, Amelie; Hallböök, Helene; Arvidson, Johan; Sällström, K. et al.

Part of Bone Marrow Transplantation, 2017

• DOI for Epstein-Barr virus-related disease after allogeneic HSCT and use of pre-emptive rituximab: Clinical Features And Outcome

Toxicity profile and treatment delays in NOPHO ALL2008-comparing adults and children with Philadelphia chromosome-negative acute lymphoblastic leukemia

Toft, Nina; Birgens, Henrik; Abrahamsson, Jonas; Griškevičius, Laimonas et al.

Part of European Journal of Haematology, p. 160-169, 2016

• DOI for Toxicity profile and treatment delays in NOPHO ALL2008-comparing adults and children with Philadelphia chromosome-negative acute lymphoblastic leukemia

Adults And Children (1-45 Years) With Ph-Negative All Have Almost Identical Outcome In Risk-Stratified Analysis Of Nopho All2008

Toft, N.; Birgens, H.; Abrahamsson, J.; Griskevicius, L. et al.

Part of Haematologica, p. 35-35, 2016

A Clinical Trial Using Third Generation CD19 Targeting CAR T Cells for Relapsed Lymphoma and Leukemia

Enblad, Gunilla; Karlsson, Hannah; Wenthe, Jessica; Wikström, Kristina I. et al.

Part of Molecular Therapy, 2016

Relapse Of Acute Lymphoblastic Leukaemia In Older/Elderly Patients - A Swedish Population-Based Study

Bergfelt, E.; Kozlowski, P.; Ahlberg, L.; Bernell, P. et al.

Part of Haematologica, p. 34-35, 2016

Ciprofloxacin prophylaxis delays initiation of broad-spectrum antibiotic therapy and reduces the overall use of antimicrobial agents during induction therapy for acute leukaemia: A single-centre study

Hallböök, Helene; Lidström, Anna-Karin; Pauksens, Karlis

Part of INFECTIOUS DISEASES, p. 443-448, 2016

• DOI for Ciprofloxacin prophylaxis delays initiation of broad-spectrum antibiotic therapy and reduces the overall use of antimicrobial agents during induction therapy for acute leukaemia: A single-centre study

Satisfactory outcome after intensive chemotherapy with pragmatic use of minimal residual disease (MRD) monitoring in older patients with Philadelphia-negative B cell precursor acute lymphoblastic leukaemia: a Swedish registry-based study

Bergfelt, Emma; Kozlowski, Piotr; Ahlberg, Lucia; Hulegardh, Erik et al.

Part of Medical Oncology, 2015

• DOI for Satisfactory outcome after intensive chemotherapy with pragmatic use of minimal residual disease (MRD) monitoring in older patients with Philadelphia-negative B cell precursor acute lymphoblastic leukaemia: a Swedish registry-based study

PROGNOSIS IN OLDER/ELDERLY PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKAEMIA DIAGNOSED 2005-2012: RESULTS FROM A SWEDISH POPULATION-BASED STUDY

Bergfelt, Emma; Kozlowski, P.; Astrom, M.; Ahlberg, L. et al.

Part of Haematologica, p. 202-202, 2015

Third Generation CD19-CAR T Cells for Relapsed and Refractory Lymphoma and Leukemia Report from the Swedish Phase I/IIa Trial

Enblad, Gunilla; Karlsson, Hannah; Wikström, Kristina; Essand, Magnus et al.

Part of Blood, 2015

Minimal Residual Disease in Adults with Philadelphia Negative B-Cell Precursor Acute Lymphoblastic Leukemia a Swedish Population-Based Study

Bergfelt, Emma; Kozlowski, P.; Ahlberg, L.; Hulegardh, E. et al.

Part of Haematologica, p. 279-280, 2014

Complying with the European Clinical Trials directive while surviving the administrative pressure: An alternative approach to toxicity registration in a cancer trial

Frandsen, Thomas Leth; Heyman, Mats; Abrahamsson, Jonas; Vettenranta, Kim et al.

Part of European Journal of Cancer, p. 251-259, 2014

• DOI for Complying with the European Clinical Trials directive while surviving the administrative pressure: An alternative approach to toxicity registration in a cancer trial

High relapse rate of T cell acute lymphoblastic leukemia in adults treated with Hyper-CVAD chemotherapy in Sweden

Kozlowski, Piotr; Astrom, Maria; Ahlberg, Lucia; Bernell, Per et al.

Part of European Journal of Haematology, p. 377-381, 2014

• DOI for High relapse rate of T cell acute lymphoblastic leukemia in adults treated with Hyper-CVAD chemotherapy in Sweden

Outcome after HSCT in Philadelphia chromosome positive acute lymphoblastic leukemia in Sweden: a population-based study

Hulegardh, E.; Hägglund, Hans; Ahlberg, L.; Karlsson, K. et al.

Part of Medical Oncology, p. 66, 2014

• DOI for Outcome after HSCT in Philadelphia chromosome positive acute lymphoblastic leukemia in Sweden: a population-based study

Survival from Acute Lymphoblastic Leukemia (ALL) in Adult Patients in the United States and Sweden: Evidence of Recent Improvement

Gustaf, Edgren; Bjorkholm, Magnus; Bernell, Per; Hallböök, Helene et al.

Part of Blood, 2014

Risk group assignment differs for children and adults 1-45 years with acute lymphoblastic leukemia treated by the NOPHO ALL-2008 protocol

Toft, Nina; Birgens, Henrik; Abrahamsson, Jonas; Bernell, Per et al.

Part of European Journal of Haematology, p. 404-412, 2013

• DOI for Risk group assignment differs for children and adults 1-45 years with acute lymphoblastic leukemia treated by the NOPHO ALL-2008 protocol

High incidence of chronic graft-versus-host disease after myeloablative allogeneic stem cell transplantation for chronic lymphocytic leukemia in Sweden: graft-versus-leukemia effect protects against relapse

Machaczka, Maciej; Johansson, Jan-Erik; Remberger, Mats; Hallböök, Helene et al.

Part of Medical Oncology, p. 762, 2013

• DOI for High incidence of chronic graft-versus-host disease after myeloablative allogeneic stem cell transplantation for chronic lymphocytic leukemia in Sweden: graft-versus-leukemia effect protects against relapse

High curability via intensive reinduction chemotherapy and stem cell transplantation in young adults with relapsed acute lymphoblastic leukemia in Sweden 2003-2007

Kozlowski, Piotr; Astrom, Maria; Ahlberg, Lucia; Bernell, Per et al.

Part of Haematologica, p. 1414-1421, 2012

• DOI for High curability via intensive reinduction chemotherapy and stem cell transplantation in young adults with relapsed acute lymphoblastic leukemia in Sweden 2003-2007

The prophylactic use of granulocyte-colony stimulating factor during remission induction is associated with increased leukaemia-free survival of adults with acute lymphoblastic leukaemia: A joint analysis of five randomised trials on behalf of the EWALL

Giebel, Sebastian; Thomas, Xavier; Hallböök, Helene; Geissler, Klaus et al.

Part of European Journal of Cancer, p. 360-367, 2012

• DOI for The prophylactic use of granulocyte-colony stimulating factor during remission induction is associated with increased leukaemia-free survival of adults with acute lymphoblastic leukaemia: A joint analysis of five randomised trials on behalf of the EWALL

Allogeneic hematopoietic stem cell transplant with reduced-intensity conditioning for chronic lymphocytic leukemia in Sweden: does donor T-cell engraftment 3 months after transplant predict survival?

Machaczka, Maciej; Johansson, Jan-Erik; Remberger, Mats; Hallböök, Helene et al.

Part of Leukemia and Lymphoma, p. 1699-1705, 2012

• DOI for Allogeneic hematopoietic stem cell transplant with reduced-intensity conditioning for chronic lymphocytic leukemia in Sweden: does donor T-cell engraftment 3 months after transplant predict survival?

Parental Age, Family Size, and Offspring's Risk of Childhood and Adult Acute Leukemia

Larfors, Gunnar; Hallböök, Helene; Simonsson, Bengt

Part of Cancer Epidemiology, Biomarkers and Prevention, p. 1185-1190, 2012

• DOI for Parental Age, Family Size, and Offspring's Risk of Childhood and Adult Acute Leukemia

Long-term survival after allogeneic stem cell transplant for relapsed large B cell lymphomas: a retrospective study

Lazarevic, Vladimir; Remberger, Mats; Hägglund, Hans; Juliusson, Gunnar et al.

Part of Leukemia and Lymphoma, p. 503-505, 2012

• DOI for Long-term survival after allogeneic stem cell transplant for relapsed large B cell lymphomas: a retrospective study

Long-term survival following allogeneic or syngeneic stem cell transplant for follicular lymphoma in Sweden

Lazarevic, Vladimir; Hägglund, Hans; Remberger, Mats; Wahlin, Anders et al.

Part of Leukemia and Lymphoma, p. 69-71, 2011

• DOI for Long-term survival following allogeneic or syngeneic stem cell transplant for follicular lymphoma in Sweden

Allogeneic haematopoietic stem-cell transplantation with reduced intensity conditioning for advanced stage Hodgkin's lymphoma in Sweden: high incidence of post transplant lymphoproliferative disorder

Johansson, J-E; Remberger, M.; Lazarevic, V. Lj; Hallböök, Helene et al.

Part of Bone Marrow Transplantation, p. 870-875, 2011

• DOI for Allogeneic haematopoietic stem-cell transplantation with reduced intensity conditioning for advanced stage Hodgkin's lymphoma in Sweden: high incidence of post transplant lymphoproliferative disorder

Myeloablative allogeneic stem cell transplantation for lymphoblastic lymphoma in Sweden: a retrospective study

Lazarevic, Vladimir Lj; Remberger, Mats; Hägglund, Hans; Hallböök, Helene et al.

Part of American Journal of Hematology, p. 709-710, 2011

• DOI for Myeloablative allogeneic stem cell transplantation for lymphoblastic lymphoma in Sweden: a retrospective study

Hematopoietic Stem Cell Transplantation Rates and Long-Term Survival in Acute Myeloid and Lymphoblastic Leukemia: Real-World Population-Based Data From the Swedish Acute Leukemia Registry 1997-2006

Juliusson, Gunnar; Karlsson, Karin; Lazarevic, Vladimir Lj; Wahlin, Anders et al.

Part of Cancer, p. 4238-4246, 2011

• DOI for Hematopoietic Stem Cell Transplantation Rates and Long-Term Survival in Acute Myeloid and Lymphoblastic Leukemia: Real-World Population-Based Data From the Swedish Acute Leukemia Registry 1997-2006

In vitro activity of imatinib in cells from patients with adult acute lymphoblastic leukemia

Hallböök, Helene; Barbany, Gisela; Åleskog, Anna; Björnberg, Annelie et al.

Part of Anti-Cancer Drugs, p. 631-634, 2005

Autologous and allogeneic stem cell transplantation in adult ALL: The Swedish Adult ALL Group experience

Hallböök, Helene; Hägglund, Hans; Stockelberg, Dick; Nilsson, Per-Gunnar et al.

Part of Bone Marrow Transplantation, p. 1141-1148, 2005

• DOI for Autologous and allogeneic stem cell transplantation in adult ALL: The Swedish Adult ALL Group experience

Hematopoietic stem cell transplantation for adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first remission: a position statement of the European Working Group for Adult Acute Lymphoblastic Leukemia (EWALL) and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)

Giebel, Sebastian; Marks, David; Boissel, Nicolas; Baron, Frederic et al.

Part of Bone Marrow Transplantation, p. 798-809, 2019

• DOI for Hematopoietic stem cell transplantation for adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first remission: a position statement of the European Working Group for Adult Acute Lymphoblastic Leukemia (EWALL) and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)

Stratification and Treatment of Adolescents and Young Adults with Acute Lymphoblastic Leukaemia

Hough, Rachael; Moorman, Anthony; Hallböök, Helene

Part of Acute Lymphoblastic Leukemia in Children and Adolescents, p. 125-133, Springer, 2024

• DOI for Stratification and Treatment of Adolescents and Young Adults with Acute Lymphoblastic Leukaemia